In general, ghrelin inhibits metabolic disorders and the apoptosis of NP cells by inhibiting the IL‐1β‐induced NK‐κB signalling pathway and stimulates the anabolic metabolism of NP cells by activating the AKT signalling pathway, thus providing a protective effect on IVD. The gene discussed is AKT1; the disease is metabolic disease.